Epstein–Barr virus (EBV) is a herpesvirus associated with lymphomas and carcinomas. While EBV-associated epithelial cell lines are good model systems to investigate the role of EBV in carcinoma, only a few cell lines are available as they are hard to acquire. A greater variety of naturally EBV-infected cell lines which are derived from tumour patients are needed to represent various features of EBVaGC. We characterized cell line YCCEL1, established from a Korean EBVaGC patient, to ascertain whether it can be used to study the roles of EBV in EBVaGC. The expression of EBV genes and cell surface markers was examined by in situ hybridization, RT-PCR, Western blot analysis, immunofluorescence assay and Northern blot analysis. EBV episomal status was analysed by Southern blotting and real-time PCR. This cell line expressed EBV nuclear antigen 1 (EBNA1) and latent membrane protein 2A (LMP2A), but not EBNA2, LMP2B nor LMP1. The majority of the lytic proteins were not detected in YCCEL1 cells either before or after treatment with 12-O-tetradecanoylphorbol-13-acetate. YCCEL1 cells expressed BART microRNAs (miRNAs) at high level but did not express BHRF1 miRNAs. YCCEL1 cells expressed cytokeratin, but not CD21 and CD19, suggesting CD21-independent EBV infection. The latent EBV gene and EBV miRNA expression pattern of YCCEL1 cells closely resembled that of general EBVaGC cases. Our results support the value of YCCEL1 cells as a good model system to study the role of EBV in gastric carcinogenesis.
BernasconiM.,
BergerC.,
SigristJ. A.,
BonanomiA.,
SobekJ.,
NiggliF. K.,
NadalD.2006; Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol J 3:43 [View Article][PubMed]
ChesnokovaL. S.,
NishimuraS. L.,
Hutt-FletcherL. M.2009; Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8. Proc Natl Acad Sci U S A 106:20464–20469 [View Article][PubMed]
HammerschmidtW.,
SugdenB.1989; Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340:393–397 [View Article][PubMed]
IwasakiY.,
ChongJ. M.,
HayashiY.,
IkenoR.,
AraiK.,
KitamuraM.,
KoikeM.,
HiraiK.,
FukayamaM.1998; Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72:8321–8326[PubMed]
KimN.,
SongY. J.,
LeeS. K.2011; The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines. Exp Mol Med 43:401–410 [View Article][PubMed]
KleinG.,
LindahlT.,
JondalM.,
LeiboldW.,
MenézesJ.,
NilssonK.,
SundströmC.1974; Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A 71:3283–3286 [View Article][PubMed]
MiddeldorpJ. M.,
BrinkA. A.,
van den BruleA. J.,
MeijerC. J.2003; Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 45:1–36 [View Article][PubMed]
MillerG.,
LipmanM.1973; Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 70:190–194 [View Article][PubMed]
MillerG.,
EndersJ. F.,
LiscoH.,
KohnH. I.1969; Establishment of lines from normal human blood leukocytes by co-cultivation with a leukocyte line derived from a leukemic child. Proc Soc Exp Biol Med 132:247–252[PubMed][CrossRef]
NemerowG. R.,
MoldC.,
SchwendV. K.,
TollefsonV.,
CooperN. R.1987; Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61:1416–1420[PubMed]
ParkJ. G.,
YangH. K.,
KimW. H.,
ChungJ. K.,
KangM. S.,
LeeJ. H.,
OhJ. H.,
ParkH. S.,
YeoK. S.other authors1997; Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70:443–449 [View Article][PubMed]
Raab-TraubN.,
FlynnK.1986; The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889 [View Article][PubMed]
SatohT.,
FukudaM.,
SairenjiT.2002; Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt’s lymphoma cell lines versus B lymphoblastoid cell lines. Virus Genes 25:15–21 [View Article][PubMed]
Shannon-LoweC. D.,
NeuhierlB.,
BaldwinG.,
RickinsonA. B.,
DelecluseH. J.2006; Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 103:7065–7070 [View Article][PubMed]
TajimaM.,
KomuroM.,
OkinagaK.1998; Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn J Cancer Res 89:262–268 [View Article][PubMed]
YoshiyamaH.,
ShimizuN.,
TakadaK.1995; Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J 14:3706–3711[PubMed]
YoshiyamaH.,
ImaiS.,
ShimizuN.,
TakadaK.1997; Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 71:5688–5691[PubMed]